AVE 33.3% 0.2¢ avecho biotechnology limited

Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial, page-5

  1. 762 Posts.
    lightbulb Created with Sketch. 108
    Why is this only being done now? The trial was announced a while back and then they seek funding to conduct it - thought this would be the other way round? And $11m, seems somewhat unrealistic to me. What happens to the trial if they don't get the funding?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.